研究方向一：子宫内膜癌的RNA异常转录分子机制和靶向药物研究

研究方向二：子宫内膜癌异常免疫微环境调控基础机制探索

研究方向三：子宫内膜癌合并代谢综合征的分子机制和临床研究

Research Direction One: RNA abnormal transcriptional molecular mechanisms and targeted drug research of endometrial cancer

Research Direction Two: Exploration of the Basic mechanisms of abnormal immune Microenvironment regulation in endometrial Cancer

Research Direction 3: Molecular mechanisms and clinical studies of endometrial cancer combined with metabolic syndrome

同济大学附属妇产科医院（上海市第一妇婴保健院）妇科肿瘤科副主任医师

同济大学附属妇产科医院（上海市第一妇婴保健院）医务部副主任（主持工作）

同济大学医学院副教授及博士生导师

梅奥医学中心分子药理学与实验治疗学研究协调员

上海市医学会妇科肿瘤学专科分会第四届委员会委员

上海研究型医院学会妇产科转化医学研究与发展专业委员会第一届委员会委员

上海市康复医学会第一届女性健康专业委员会委员

上海女医师学会妇儿专业委员会委员

上海医学会妇科肿瘤分会第三届青委会委员及秘书

上海市康复医学会第一届女性健康专委会委员

上海市卵巢癌协作组成员

上海研究型医院学会妇产科转化医学研究与发展专业委员会第一届委员会委员

Deputy Chief Physician of the Department of Gynecological Oncology, Obstetrics and Gynecology Hospital Affiliated to Tongji University

Deputy Director of the Medical Affairs Department (in charge of Work) of the Obstetrics and Gynecology Hospital Affiliated to Tongji University

Associate Professor and Doctoral Supervisor at the School of Medicine, Tongji University

Research Coordinator of Molecular Pharmacology and Experimental Therapeutics at the Mayo Clinic

Member of the Fourth Committee of the Gynecological Oncology Branch of the Shanghai Medical Association

Member of the First Committee of the Obstetrics and Gynecology Translational Medicine Research and Development Professional Committee of the Shanghai Research Hospital Society

Member of the First Women's Health Professional Committee of the Shanghai Rehabilitation Medical Association

Member of the Women and Children's Professional Committee of the Shanghai Women Physicians Association

Member and Secretary of the Third Youth Committee of the Gynecological Oncology Branch of the Shanghai Medical Association

Member of the First Women's Health Committee of the Shanghai Rehabilitation Medical Association

Member of the Shanghai Ovarian Cancer Collaboration Group

Member of the First Committee of the Obstetrics and Gynecology Translational Medicine Research and Development Professional Committee of the Shanghai Research Hospital Society

目前担任同济大学附属妇产科医院（上海市第一妇婴保健院）妇科肿瘤科副主任医师、医务部副主任（主持工作）、同济大学医学院副教授及博士生导师、上海市医学会妇科肿瘤分会委员及内膜癌学组成员等学术任职，主持12 项相关研究，其中3 项获国自然科学基金资助，获上海市卫生系统“银蛇奖”、上海市“东方英才”青年计划、上海市青年五四奖章（个人）及浦东新区十大杰出青年等院、校级以上人才计划多项。现担任世界顶尖的医学研究机构——梅奥医学中心（Mayo Clinic）分子药理学与实验治疗学（Molecular pharmacology andexperimental therapeutics，MPET）的研究协调员，深度参与了多项重大研究项目，积累了丰富的分子靶向治疗抑制剂研发经验，为课题的顺利开展奠定了坚实的基础。主要从事内膜癌相关的基础及转化研究，集中探索了内膜癌肿瘤微环境调控分子机制，以第一/通讯作者发表SCI 二十篇，被引千余次。

Dr. Li currently holds academic positions such as Deputy Chief Physician of the Department of Gynecological Oncology at the Obstetrics and Gynecology Hospital Affiliated to Tongji University (Shanghai First Maternity and Infant Hospital), Deputy Director of the Medical Affairs Department (in charge of work), Associate professor and Doctoral Supervisor at Tongji University School of Medicine, member of the Gynecological Oncology Branch of the Shanghai Medical Association, and member of the Endometrial Cancer Group. She has led 12 related research projects. Among them, three projects were funded by the National Natural Science Foundation of China, and multiple talent programs at or above the college and university levels were received, including the "Silver Snake Award" of the Shanghai Health System, the "Oriental Talent" Youth Program of Shanghai, the Shanghai Youth May 4th Medal (Individual), and the "Top Ten Outstanding Youth of Pudong New Area". Currently serving as the research coordinator of Molecular pharmacology and Experimental therapeutics (MPET) at the Mayo Clinic, a world-leading medical research institution. Deeply involved in multiple major research projects, Dr. Li accumulated rich experience in the research and development of molecular targeted therapy inhibitors, laying a solid foundation for the smooth progress of the project. Mainly engaged in basic and translational research related to endometrial cancer, with a focus on exploring the molecular mechanisms of tumor microenvironment regulation in endometrial cancer. Published twenty SCI papers as the first or corresponding author, which have been cited over a thousand times.